Today’s biotech news highlights a promising yet controversial gene therapy approach, sparking both enthusiasm and skepticism within the field. Additionally, Jennifer Doudna is advancing into artificial intelligence-designed gene editors, aiming to innovate beyond traditional evolutionary methods. Lastly, discussions are underway about Kalshi’s recent venture into biotech within the prediction market space. For deeper insights, consider subscribing to get more detailed updates and analyses.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.statnews.com/2026/07/17/biotech-news-gsk-chronic-cough-treatment-meets-the-end-of-the-line/
